Suchergebnisse - "Ferrari, Vittorio D."

PubPharm (30)

1

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

enthalten in: Endocrine | 2021

von Tovazzi, V. | Ferrari, V. | Berruti, A.

CommentOn: Endocrine. 2020 Sep;69(3):481-484. - PMID 32488839

2

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

enthalten in: Endocrine | 2021

von Tovazzi, V. | Ferrari, V. | Berruti, A.

3

Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?

enthalten in: Minerva urologica e nefrologica = The Italian journal of urology and nephrology | 2020

von Dalla Volta, A. | Valcamonico, F. | Zamboni, S. | +4

4

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view

enthalten in: Endocrine | 2020

von Tovazzi, V. | Ferrari, V. | Dalla Volta, A. | +3

CommentIn: Endocrine. 2021 Jan;71(1):256-257. - PMID 33394384

5

Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view

enthalten in: Endocrine | 2020

von Tovazzi, V. | Ferrari, V. | Dalla Volta, A. | +3

6

Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view

enthalten in: Endocrine | 2020

von Tovazzi, V. | Ferrari, V. | Dalla Volta, A. | +3

7

Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view

enthalten in: Endocrine | 2020

von Tovazzi, V. | Ferrari, V. | Dalla Volta, A. | +3

8

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients

enthalten in: European journal of endocrinology | 2019

von Cosentini, D. | Badalamenti, G. | Grisanti, S. | +16

9

Second line treatment of recurrent glioblastoma with sunitinib : results of a phase II study and systematic review of literature

enthalten in: Journal of neurosurgical sciences | 2019

von Grisanti, S. | Ferrari, V. | Buglione, M. | +13

10

Eight-week interval in flushing and locking port-a-cath in cancer patients : A single-institution experience and systematic review

enthalten in: European journal of cancer care | 2019

von Fornaro, C. | Piubeni, M. | Tovazzi, V. | +13